Related Experiment Video
Updated: Aug 11, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus
J Dumortier1, K Schönig, H Oberwinkler
1Department of Virology, University of Heidelberg, Heidelberg, Germany.
Abstract:
Interferons control viral replication and the growth of some malignant tumors. Since systemic application may cause severe adverse effects, tissue-specific expression is an attractive alternative. Liver-directed interferon gene therapy offers promising applications such as chronic viral hepatitis B or C or hepatocellular carcinoma and thus needs testing in vivo in suitable animal models. We therefore used the Tet-On system to regulate gene expression in adenoviral vectors, and studied the effect of liver-specific and regulated interferon gamma expression in a mouse model of chronic hepatitis B virus (HBV) infection. In a first generation adenoviral vector, genes encoding for firefly luciferase and interferons alpha, beta or gamma, respectively, were coexpressed under control of the bidirectional tetracycline-regulated promoter P(tet)bi. Liver-specific promoters driving expression of the reverse tetracycline controlled transactivator ensured local expression in the livers of HBV transgenic mice. Following gene transfer, we demonstrated low background, tight regulation and a 1000-fold induction of gene expression by doxycycline. Both genes within the bidirectional transcription unit were expressed simultaneously, and in a liver-specific fashion in cell culture and in living mice. Doxycycline-dependent interferon gamma expression effectively controlled HBV replication in mice, but did not eliminate HBV transcripts. This system will help to study the effects of local cytokine expression in mouse disease models in detail.
Insights
This study developed a liver-specific gene therapy system using Tet-On technology to control interferon gamma expression in mice with chronic hepatitis B virus (HBV) infection. The system effectively reduced HBV replication in vivo.
Area of Science:
- Gene therapy
- Immunology
- Hepatology
Background:
- Systemic interferon therapy for viral infections and cancer has limitations due to adverse effects.
- Tissue-specific gene expression is a promising alternative for localized therapeutic benefits.
- Liver-directed gene therapy is being explored for chronic viral hepatitis and hepatocellular carcinoma.
Purpose of the Study:
- To develop and evaluate a liver-specific, regulated gene expression system for interferon gamma in a mouse model of chronic hepatitis B virus (HBV) infection.
- To assess the efficacy of doxycycline-inducible interferon gamma expression in controlling HBV replication.
- To establish a tool for studying local cytokine effects in disease models.
Main Methods:
- Utilized adenoviral vectors with a Tet-On system for regulated gene expression.
- Coexpressed firefly luciferase and interferons (alpha, beta, gamma) under a bidirectional tetracycline-regulated promoter.
- Employed liver-specific promoters for the reverse tetracycline-controlled transactivator in HBV transgenic mice.
- Administered doxycycline to induce gene expression and monitored HBV replication.
Main Results:
- Achieved low background, tightly regulated, and over 1000-fold induction of gene expression with doxycycline.
- Demonstrated simultaneous and liver-specific expression of coexpressed genes in vitro and in vivo.
- Doxycycline-induced interferon gamma expression significantly controlled HBV replication in mice.
- HBV transcripts were not eliminated by the treatment.
Conclusions:
- The developed Tet-On system enables precise, liver-specific, and inducible expression of therapeutic genes like interferon gamma.
- This system effectively reduces viral replication in a relevant disease model.
- It provides a valuable platform for further research into localized cytokine therapy and disease mechanisms.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis

